Painful acute thyroiditis following a first cure of Ipilimumab plus Nivolumab for metastatic melanoma

被引：2
|
作者：
Montaudie, Henri [1 ,2 ]
Picard, Alexandra [1 ]
Panaia-Ferrari, Patricia [3 ]
Boukari, Feriel [1 ]
Passeron, Thierry [1 ,2 ]
Sadoul, Jean-Louis [3 ]
Brucker-Davis, Francoise [3 ]
机构：
[1] Univ Hosp Nice, Archet 2 Hosp, Dept Dermatol, Nice, France
[2] INSERM, Ctr Mediterraneen Med Mol, Nice, France
[3] Cote Azur Univ, Univ Hosp Nice, Archet 2 Hosp, Dept Endocrinol Diabetol & Reprod Med, Nice, France
来源：
MELANOMA RESEARCH | 2018年 / 28卷 / 04期
关键词：
D O I：
10.1097/CMR.0000000000000460
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：368 / 369
页数：2
相关论文
共 50 条
  • [41] Complete Remission of Metastatic Melanoma of the Scalp Following Treatment With Nivolumab Plus Relatlimab
    McMinn, Mary E.
    Brister, Kelly A.
    Orr, W. Shannon
    Sheehan, Natale T.
    Christopher, Wade O.
    AMERICAN SURGEON, 2024, 90 (08) : 2078 - 2079
  • [42] Acute renal transplant rejection following nivolumab therapy for metastatic melanoma
    Tan, Brandon
    Baxter, Mark
    Casasola, Richard
    BMJ CASE REPORTS, 2021, 14 (02)
  • [43] Adjuvant Nivolumab or Ipilimumab plus Nivolumab for Melanoma Determined by Pathological Response to a Single Dose of Neoadjuvant Nivolumab
    Khan, Tahsin M.
    Teke, Martha E.
    Karakousis, Giorgos C.
    Miura, John T.
    Brody, Robert M.
    Hernandez, Jonathan M.
    Mitchell, Tara C.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (05) : 2771 - 2772
  • [44] Meningoencephalitis Following Ipilimumab Administration in Metastatic Melanoma
    Stein, Matthew K.
    Summers, Bryant B.
    Wong, Christine A.
    Box, Hilary L.
    Cleveland, Kerry O.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 350 (06): : 512 - 513
  • [45] Timing of brain metastases in relation to outcome during first-line ipilimumab plus nivolumab therapy for metastatic melanoma in a community oncology practice
    Ong, Claire Victoria
    Samlowski, Wolfram
    JOURNAL OF NEURO-ONCOLOGY, 2025, 172 (03) : 645 - 653
  • [46] Case Report: Thrombotic-Thrombocytopenic Purpura Following Ipilimumab and Nivolumab Combination Immunotherapy for Metastatic Melanoma
    Mullally, W. J.
    Cooke, F. J.
    Crosbie, I. M.
    Kumar, S.
    Abernethy, V. E.
    Jordan, E. J.
    O'Connor, M.
    Horgan, A. M.
    Landers, R.
    Naidoo, J.
    Calvert, P. M.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
    Robert, Caroline
    Thomas, Luc
    Bondarenko, Igor
    O'Day, Steven
    Weber, Jeffrey
    Garbe, Claus
    Lebbe, Celeste
    Baurain, Jean-Francois
    Testori, Alessandro
    Grob, Jean-Jacques
    Davidson, Neville
    Richards, Jon
    Maio, Michele
    Hauschild, Axel
    Miller, Wilson H., Jr.
    Gascon, Pere
    Lotem, Michal
    Harmankaya, Kaan
    Ibrahim, Ramy
    Francis, Stephen
    Chen, Tai-Tsang
    Humphrey, Rachel
    Hoos, Axel
    Wolchok, Jedd D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26): : 2517 - 2526
  • [48] The best dosage of nivolumab plus ipilimumab combination for melanoma brain metastases
    Fukumoto, Takeshi
    Horita, Nobuyuki
    TRANSLATIONAL ONCOLOGY, 2022, 22
  • [49] Ipilimumab/Nivolumab-related orthostatic myoclonus in a patient with metastatic melanoma
    Green, B.
    Tse, W.
    MOVEMENT DISORDERS, 2023, 38 : S251 - S251
  • [50] Neurologic Complications Effects of ipilimumab and nivolumab therapy in patients with metastatic melanoma
    Latchman, Jessica
    Guastella, Ann
    Tofthagen, Cindy
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2019, 23 (04) : 355 - 358
12345